Published: Tue, May 14, 2019
Worldwide | By Isabel Fisher

Drug Makers Accused of Price-Fixing on Dozens of Generic Drugs

Drug Makers Accused of Price-Fixing on Dozens of Generic Drugs

The attorneys general claim that the prices of more than 100 drugs were artificially inflated thanks to the practices of Teva, Novartis' Sandoz unit, Pfizer, Mylan and others between 2012 and 2015.

You can see a complete lists of the states filing suit and the drug makers here.

Schmitt's Kansas counterpart, Derek Schmidt, issued a release saying the drugs mentioned in the lawsuit amounted to billions of dollars of sales in the United States.

The new lawsuit is the second filed by the office against the generic drug industry, both arising from an investigation opened in July 2014, during the administration of Tong's predecessor, George Jepsen.

The drugs included everything from tablets and capsules to creams and ointments to treat conditions including diabetes, high cholesterol, high blood pressure, cancer, epilepsy and more, they said.

In a statement, a representative of Teva USA denied the allegations.

In response, Teva said in a statement: "The allegations in this new complaint, and in the litigation more generally, are just that - allegations".

A spokesman for Teva Pharmaceuticals, one of the companies named in the suit, said Teva hasn't engaged in any conduct that would lead to civil or criminal liability.

The complaint was filed in the District Court for the District of CT and names Teva Pharmaceuticals along with 19 other companies and 15 individuals who are senior executives at the heart of the scandal.

The lawsuit expands on an earlier case brought by CT and 19 other states in December 2016.

According to Bloomberg, Teva helped mastermind a sweeping conspiracy among generic pharmaceutical giants to raise prices for medicines.

The suit contends that this resulted in "many billions of dollars of harm to the national economy over a period of several years".

Tong said, "Right before, right after, right around when there is a major price spike in a generic drug the chatter among competitors reaches nearly a frenetic frantic pace where you have calls".

This complaint follows one filed in 2017 that is still pending before the Eastern District of Pennsylvania charging 18 corporate defendants about 14 drugs.

Two former executives from Heritage Pharmaceuticals, Jeffery Glazer and Jason Malek, have entered into settlement agreements and are cooperating with the attorneys general working group in that case.

'The company delivers high-quality medicines to patients around the world and is committed to complying with all applicable laws and regulations in doing so'. The state is seeking relief, including triple damages for ME governmental and consumer purchasers, civil penalties, a court order that compels defendants to refrain from certain behaviors, attorney's fees and investigative and litigation costs.

Other companies named in the report include Pfizer Inc.

Like this: